Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
21.20
+0.41 (1.97%)
Nov 21, 2024, 3:49 PM EST - Market open
Privia Health Group Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Privia Health Group stock have an average target of 24.77, with a low estimate of 20 and a high estimate of 30. The average target predicts an increase of 16.84% from the current stock price of 21.20.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PRVA stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 6 | 5 | 6 | 6 | 7 | 7 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $19 → $21 | Hold | Maintains | $19 → $21 | -0.94% | Nov 8, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $24 → $27 | Strong Buy | Maintains | $24 → $27 | +27.36% | Nov 8, 2024 |
| Keybanc | Keybanc | Buy Initiates $23 | Buy | Initiates | $23 | +8.49% | Oct 11, 2024 |
| Baird | Baird | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +13.21% | Aug 26, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $28 | Buy | Reiterates | $28 | +32.08% | Aug 14, 2024 |
Financial Forecast
Revenue This Year
2.95B
from 1.66B
Increased by 77.95%
Revenue Next Year
3.31B
from 2.95B
Increased by 12.03%
EPS This Year
0.14
from 0.19
Decreased by -24.07%
EPS Next Year
0.25
from 0.14
Increased by 76.26%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.1B | 3.5B | 4.1B | ||
| Avg | 3.0B | 3.3B | 3.7B | ||
| Low | 2.8B | 3.1B | 3.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 89.5% | 19.3% | 23.1% | ||
| Avg | 78.0% | 12.0% | 12.5% | ||
| Low | 69.0% | 3.7% | 0.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.20 | 0.38 | 1.01 |
| Avg | 0.14 | 0.25 | 0.41 |
| Low | 0.11 | 0.14 | 0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.0% | 162.0% | 296.4% |
| Avg | -24.1% | 76.3% | 62.3% |
| Low | -43.3% | -4.9% | -11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.